Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published 2010 | Published
Journal Article Open

Antibody therapy in Neurodegenerative Disease

Abstract

Advances in medical science have led to increased life expectancy and increased median age in the population. Because the symptoms of neurodegenerative diseases generally onset in mid- to late-life, a concomitant increase in the number of persons afflicted with these devastating diseases has occurred. Developing therapies for neurodegenerative diseases is of the highest priority due to the enormous cost of medical care required, as well as for the human suffering involved. Although caused by a variety of genetic and environmental insults, such diseases share commonalities. Many of these diseases are proteinopathies-diseases caused by misfolded, aggregating proteins. Antibodies that can recognize and remove misfolded proteins are ideally suited for proteinopathy therapeutics. The numerous intriguing advances in antibody-based therapies for neurodegenerative diseases are discussed in this review.

Additional Information

© 2010 Freund & Pettman. Accepted: May 28, 2010. Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIH P41 RR-O I 081).

Attached Files

Published - Southwell2010p11747Rev_Neuroscience.pdf

Files

Southwell2010p11747Rev_Neuroscience.pdf
Files (1.1 MB)
Name Size Download all
md5:17daca107993e8b9bb90a07203e17bca
1.1 MB Preview Download

Additional details

Created:
August 21, 2023
Modified:
October 20, 2023